ERBB2 and breast carcinoma: In summary, our results add a new layer of functional complexity to the HER2 oncogene, expand the repertoire of regulatory miRNA-target gene interactions and demonstrate the existence of a direct RNA-RNA crosstalk between the two major therapeutic breast cancer biomarkers.